InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-32.9%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by RAPP MICHAEL, Director. Officer active across 2 companies, notably Immunome Inc.. Aggregated, 9 filings have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €2.1m. History available since 24 May 2021. The latest transaction was disclosed on 2 October 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
253,806 shares@ US$5.9140.0% of flowCommon StockSEC:0001104659-23-106486:0
17,500 shares@ US$4.001.8% of flowCommon StockSEC:0001104659-23-004001:0
25,962 shares@ US$19.960.019% mcap21.1% of flowCommon StockSEC:0001104659-21-115280:0
Ideal exit: 10 Jun 2022 (T+270)
25,962 shares@ US$19.9612.3% of flowCommon StockSEC:0001104659-21-115280
Ideal exit: 10 Jun 2022 (T+270)
8,170 shares@ US$17.440.0051% mcap5.8% of flowCommon StockSEC:0001104659-21-114881:0
Ideal exit: 6 Jun 2022 (T+270)
8,170 shares@ US$17.443.4% of flowCommon StockSEC:0001104659-21-114881
Ideal exit: 6 Jun 2022 (T+270)
31,895 shares@ US$18.380.020% mcap23.1% of flowCommon StockSEC:0001104659-21-072620:0
Ideal exit: 18 Feb 2022 (T+270)
31,895 shares@ US$18.3823.1% of flowCommon StockSEC:0001104659-21-072620
Ideal exit: 18 Feb 2022 (T+270)
80,467 sharesCommon StockSEC:0001144204-16-082395:0
9 of 9 declarations
About RAPP MICHAEL
Michael Rapp is a Board Member at Immunome Inc. In this role, he contributes to overseeing the company's activities and making strategic decisions. Rapp brings his expertise in corporate governance and biotechnology, which is essential for guiding the organization's direction. His commitment to innovation and research is an asset to the board.
